Eckelman Brendan P.

Officer at Inhibrx, Inc.

Sold, on record
$17.2M
Dollars the filings state
Form 4 sales
9
Latest May 28, 2024
Form 144 notices
6
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Inhibrx, Inc.Plan not stated
    Feb 2 2023

    Sold 40,000 shares at $24.93 ($997k)

    Eckelman Brendan P., Chief Scientific Officer

    Sold 1.9% of holdings ($52.7M position)2.1M shares left1x usual sizeFiling

  2. 2 Form 144 notice Inhibrx, Inc.Notice
    Mar 8 +400 days

    Filed to sell 2,150 shares ($77k)

    Eckelman Brendan P., Officer

    No 10b5-1 plan0.1x usual sizeFiling

  3. 3 Form 144 notice Inhibrx, Inc.Notice
    Mar 11 +3 days

    Filed to sell 13,558 shares ($479k)

    Eckelman Brendan P., Officer

    No 10b5-1 plan0.3x usual sizeFiling

  4. 4 Form 144 notice Inhibrx, Inc.Notice
    Mar 12 +1 day

    Filed to sell 24,050 shares ($848k)

    Eckelman Brendan P., Officer

    No 10b5-1 plan0.6x usual sizeFiling

  5. 5 Form 144 notice Inhibrx, Inc.Notice
    Mar 13 +1 day

    Filed to sell 1,898 shares ($67k)

    Eckelman Brendan P., Officer

    No 10b5-1 plan0x usual sizeFiling

  6. 6 Form 144 notice Inhibrx, Inc.Notice
    May 22 +70 days

    Filed to sell 5,010 shares ($171k)

    Eckelman Brendan P., Officer

    No 10b5-1 plan0.1x usual sizeFiling

  7. 7 Form 144 notice Inhibrx, Inc.Notice
    May 28 +6 days

    Filed to sell 300,000 shares ($10.3M)

    Eckelman Brendan P., Officer

    No 10b5-1 plan7.5x usual sizeFiling

  8. 8 Form 4 sale Inhibrx, Inc.Unusual
    May 28 same day

    Sold 300,000 shares at $34.30 ($10.3M)

    Eckelman Brendan P., Chief Scientific Officer

    No 10b5-1 planSold 14.7% of holdings ($69.8M position)1.7M shares left7.5x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Eckelman Brendan P.
Source
May 28, 2024Inhibrx, Inc.Chief Scientific OfficerForm 4 sale300,000$10.3M14.7%UnusualSEC
May 28, 2024Inhibrx, Inc.OfficerForm 144 notice300,000$10.3MNoticeSEC
May 22, 2024Inhibrx, Inc.OfficerForm 144 notice5,010$171kNoticeSEC
Mar 13, 2024Inhibrx, Inc.OfficerForm 144 notice1,898$67kNoticeSEC
Mar 12, 2024Inhibrx, Inc.OfficerForm 144 notice24,050$848kNoticeSEC
Mar 11, 2024Inhibrx, Inc.OfficerForm 144 notice13,558$479kNoticeSEC
Mar 8, 2024Inhibrx, Inc.OfficerForm 144 notice2,150$77kNoticeSEC
Feb 2, 2023Inhibrx, Inc.Chief Scientific OfficerForm 4 sale40,000$997k1.9%Plan not statedSEC
Dec 6, 2022Inhibrx, Inc.Chief Scientific OfficerForm 4 sale40,000$1.1M1.8%Plan not statedSEC
Nov 1, 2022Inhibrx, Inc.Chief Scientific OfficerForm 4 sale40,000$1.3M1.8%Plan not statedSEC
Oct 4, 2022Inhibrx, Inc.Chief Scientific OfficerForm 4 sale40,000$1.1M1.8%Plan not statedSEC
Sep 6, 2022Inhibrx, Inc.Chief Scientific OfficerForm 4 sale40,000$596k1.6%Plan not statedSEC
Aug 3, 2022Inhibrx, Inc.Chief Scientific OfficerForm 4 sale40,000$720k1.6%Plan not statedSEC
Jul 7, 2022Inhibrx, Inc.Chief Scientific OfficerForm 4 sale40,000$687k1.6%Plan not statedSEC
Mar 24, 2021Inhibrx, Inc.Chief Scientific OfficerForm 4 sale17,000$323k0.7%Plan not statedSEC